[1]
M. Misiuk-Hojło and K. Czajor, “Systemic pharmacokinetics of intravitreal anti-VEGF medications in wet AMD treatment”, Ophthatherapy, vol. 3, no. 1, pp. 4-10, Mar. 2016.